LEMAITRE VASCULAR, INC. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
LEMAITRE VASCULAR, INC. (LMAT) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $6.23 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-08-05
- LEMAITRE VASCULAR, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-06-30 was $1.16M, a 59.32% increase year-over-year.
- LEMAITRE VASCULAR, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-03-31 was $5.07M, a 8641.38% increase year-over-year.
- LEMAITRE VASCULAR, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-12-31 was $531.00K, a 0.19% decline year-over-year.
- LEMAITRE VASCULAR, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-09-30 was $215.00K, a 44.59% decline year-over-year.
- LEMAITRE VASCULAR, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $1.53M, a 6.29% decline from fiscal 2024.
- LEMAITRE VASCULAR, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $1.64M, a 65.99% decline from fiscal 2023.
- LEMAITRE VASCULAR, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $4.81M, a 74.01% increase from fiscal 2022.
- LEMAITRE VASCULAR, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $2.77M, a 116.60% increase from fiscal 2021.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $6.23M 10-Q · filed 2026-08-05 | $6.76M derived: sum of 3 quarters · filed 2026-08-05 | $6.98M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $5.07M 10-Q · filed 2026-05-06 | $5.60M derived: sum of 2 quarters · filed 2026-05-06 | $5.82M derived: sum of 3 quarters · filed 2026-05-06 | $6.55M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $531.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $746.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.48M derived: sum of 3 quarters · filed 2026-08-05 | $1.53M 10-K · filed 2026-02-26 |
| 2025-09-30 | $215.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $945.00K derived: sum of 2 quarters · filed 2026-08-05 | $1.00M 10-Q · filed 2025-11-07 | $1.53M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $730.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $788.00K 10-Q · filed 2026-08-05 | $1.32M derived: sum of 3 quarters · filed 2026-08-05 | $1.71M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $58.00K 10-Q · filed 2026-05-06 | $590.00K derived: sum of 2 quarters · filed 2026-05-06 | $978.00K derived: sum of 3 quarters · filed 2026-05-06 | $1.19M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $532.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $920.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.13M derived: sum of 3 quarters · filed 2026-02-26 | $1.64M 10-K · filed 2026-02-26 |
| 2024-09-30 | $388.00K 10-Q · filed 2024-11-08 | $596.00K derived: sum of 2 quarters · filed 2024-11-08 | $1.10M 10-Q · filed 2025-11-07 | $3.76M derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-06-30 | $208.00K 10-Q · filed 2024-08-08 | $717.00K 10-Q · filed 2025-08-06 | $3.37M derived: sum of 3 quarters · filed 2025-05-08 | $4.22M derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-03-31 | $509.00K 10-Q · filed 2025-05-08 | $3.17M derived: sum of 2 quarters · filed 2025-05-08 | $4.01M derived: sum of 3 quarters · filed 2025-05-08 | $4.85M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $2.66M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $3.50M derived: sum of 2 quarters · filed 2025-02-28 | $4.34M derived: sum of 3 quarters · filed 2025-02-28 | $4.81M 10-K · filed 2025-02-28 |
| 2023-09-30 | $843.00K 10-Q · filed 2024-11-08 | $1.68M derived: sum of 2 quarters · filed 2024-11-08 | $2.16M 10-Q · filed 2024-11-08 | $2.25M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $841.00K 10-Q · filed 2024-08-08 | $1.31M 10-Q · filed 2024-08-08 | $1.41M derived: sum of 3 quarters · filed 2024-08-08 | $1.70M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $472.00K 10-Q · filed 2024-05-10 | $569.00K derived: sum of 2 quarters · filed 2024-05-10 | $856.00K derived: sum of 3 quarters · filed 2024-05-10 | $3.10M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $97.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $384.00K derived: sum of 2 quarters · filed 2024-02-29 | $2.62M derived: sum of 3 quarters · filed 2024-02-29 | $2.77M 10-K · filed 2024-02-29 |
| 2022-09-30 | $287.00K 10-Q · filed 2023-11-07 | $2.53M derived: sum of 2 quarters · filed 2023-11-07 | $2.67M 10-Q · filed 2023-11-07 | $2.67M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $2.24M 10-Q · filed 2023-08-08 | $2.38M 10-Q · filed 2023-08-08 | $2.38M derived: sum of 3 quarters · filed 2023-08-08 | $2.38M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $141.00K 10-Q · filed 2023-05-09 | $141.00K derived: sum of 2 quarters · filed 2023-05-09 | $141.00K derived: sum of 3 quarters · filed 2023-05-09 | $1.40M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $0.00 derived: sum of 2 quarters · filed 2023-03-01 | $1.26M derived: sum of 3 quarters · filed 2023-03-01 | $1.28M 10-K · filed 2023-03-01 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-08 | $1.26M derived: sum of 2 quarters · filed 2022-11-08 | $1.28M 10-Q · filed 2022-11-08 | $1.47M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $1.26M 10-Q · filed 2022-08-05 | $1.28M 10-Q · filed 2022-08-05 | $1.47M derived: sum of 3 quarters · filed 2022-08-05 | $1.57M derived: sum of 4 quarters · filed 2022-08-05 |
| 2021-03-31 | $16.00K 10-Q · filed 2022-05-10 | $209.00K derived: sum of 2 quarters · filed 2022-05-10 | $305.00K derived: sum of 3 quarters · filed 2022-05-10 | $2.64M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $193.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $289.00K derived: sum of 2 quarters · filed 2022-02-28 | $2.62M derived: sum of 3 quarters · filed 2022-02-28 | $2.77M 10-K · filed 2022-02-28 |
| 2020-09-30 | $96.00K 10-Q · filed 2021-11-04 | $2.43M derived: sum of 2 quarters · filed 2021-11-04 | $2.58M 10-Q · filed 2021-11-04 | $12.27M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $2.33M 10-Q · filed 2021-08-05 | $2.48M 10-Q · filed 2021-08-05 | $12.17M derived: sum of 3 quarters · filed 2021-08-05 | $12.24M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $149.00K 10-Q · filed 2021-05-10 | $9.84M derived: sum of 2 quarters · filed 2021-05-10 | $9.91M derived: sum of 3 quarters · filed 2021-05-10 | $10.50M derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | $9.69M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $9.76M derived: sum of 2 quarters · filed 2021-03-12 | $10.36M derived: sum of 3 quarters · filed 2021-03-12 | $10.57M 10-K · filed 2021-03-12 |
| 2019-09-30 | $69.00K 10-Q · filed 2020-11-06 | $663.00K derived: sum of 2 quarters · filed 2020-11-06 | $879.00K 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $594.00K 10-Q · filed 2020-08-06 | $810.00K 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | $217.00K 10-Q · filed 2020-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |